Novartis Discontinues Mid-Stage Lupus Trial of Iptacopan
Novartis has discontinued its mid-stage trial of iptacopan in lupus nephritis, citing strategic considerations in a clinical-trials registry update.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.